Polymorphisms of Homologous Recombination RAD51, RAD51B, XRCC2, and XRCC3 Genes and the Risk of Prostate Cancer

Table 1

Clinical characteristic of studied material.

	Prostate cancer patients	Control group
Age (year)
Range	49–86	43–84
Mean ± SD	71 ± 9	63 ± 9
Median	71	63
PSAT (ng/mL)
Range	4.01–1489	0.004–3.94
Mean ± SD	59.96 ± 182.67	1.09 ± 0.88
Median	10.57	0.90